Literature DB >> 17673878

Loop diuretic therapy, thiamine balance, and heart failure.

Domenic A Sica1.   

Abstract

Thiamine, or vitamin B1, is a water-soluble B complex vitamin that was first discovered in 1910 in the process of exploring how rice bran cured patients of beriberi. Thiamine is not synthesized in humans, therefore its availability for necessary cellular processes hinges on its continual ingestion. The amount of thiamine one needs to ingest to maintain balance is disease state-dependent or medication-dependent. Severe chronic thiamine deficiency can have significant neurologic and cardiac effects, the latter is reflected in a particular type of heart failure called wet beriberi. This form of heart failure clearly benefits from thiamine supplementation. It is unclear, however, whether thiamine supplementation offers any benefit in other forms of heart failure. Despite this, it is not unreasonable for heart failure patients to routinely ingest a thiamine-containing multivitamin; patients using diuretics have an increased urinary excretion of thiamine and thus are at a higher risk for developing thiamine deficiency. The role of thiamine in heart failure, however, remains arguable.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17673878     DOI: 10.1111/j.1527-5299.2007.06260.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  24 in total

1.  Do not forget to give thiamine to your septic shock patient!

Authors:  Jihad Mallat; Malcolm Lemyze; Didier Thevenin
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

2.  Thiamine as a metabolic resuscitator in septic shock: one size does not fit all.

Authors:  Nara A Costa; Paula S Azevedo; Bertha F Polegato; Leonardo A M Zornoff; Sergio A R Paiva; Marcos F Minicucci
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 3.  Emerging Concepts in Nutrient Needs.

Authors:  Patrick J Stover; Cutberto Garza; Jane Durga; Martha S Field
Journal:  J Nutr       Date:  2020-10-01       Impact factor: 4.798

4.  Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway.

Authors:  Johannes A Mayr; Peter Freisinger; Kurt Schlachter; Boris Rolinski; Franz A Zimmermann; Thomas Scheffner; Tobias B Haack; Johannes Koch; Uwe Ahting; Holger Prokisch; Wolfgang Sperl
Journal:  Am J Hum Genet       Date:  2011-12-09       Impact factor: 11.025

Review 5.  Thiamine Deficiency and Neurodegeneration: the Interplay Among Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy.

Authors:  Dexiang Liu; Zunji Ke; Jia Luo
Journal:  Mol Neurobiol       Date:  2016-09-05       Impact factor: 5.590

6.  Gene expression and histopathological evaluation of thiamine pyrophosphate on optic neuropathy induced with ethambutol in rats.

Authors:  Emine Cinici; Nihal Cetin; Bahadir Suleyman; Durdu Altuner; Oguzhan Yarali; Hilal Balta; Ilknur Calik; Levent Tumkaya; Halis Suleyman
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

Review 7.  Thiamin deficiency and heart failure: the current knowledge and gaps in literature.

Authors:  Mavra Ahmed; Parastoo Azizi-Namini; Andrew T Yan; Mary Keith
Journal:  Heart Fail Rev       Date:  2015-01       Impact factor: 4.214

Review 8.  Evidence for altered thiamine metabolism in diabetes: Is there a potential to oppose gluco- and lipotoxicity by rational supplementation?

Authors:  Lukáš Pácal; Katarína Kuricová; Kateřina Kaňková
Journal:  World J Diabetes       Date:  2014-06-15

9.  Nonalcoholic Thiamine-Related Encephalopathy (Wernicke-Korsakoff Syndrome) Among Inpatients With Cancer: A Series of 18 Cases.

Authors:  Elie Isenberg-Grzeda; Yesne Alici; Vaios Hatzoglou; Christian Nelson; William Breitbart
Journal:  Psychosomatics       Date:  2015-10-23       Impact factor: 2.386

10.  Thiamine status in end-stage chronic kidney disease patients: a single-center study.

Authors:  Yosuke Saka; Tomohiko Naruse; Akihisa Kato; Naoto Tawada; Yuhei Noda; Tetsushi Mimura; Yuzo Watanabe
Journal:  Int Urol Nephrol       Date:  2018-09-04       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.